Article 1
Annexes II, III and V to Regulation (EC) No 1223/2009 are amended in accordance with the Annex to this Regulation.
Commission Regulation (EU) 2021/1902 of 29 October 2021 amending Annexes II, III and V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards the use in cosmetic products of certain substances classified as carcinogenic, mutagenic or toxic for reproduction (Text with EEA relevance)
Commission Regulation (EU) 2021/1902 of 29 October 2021 amending Annexes II, III and V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards the use in cosmetic products of certain substances classified as carcinogenic, mutagenic or toxic for reproduction (Text with EEA relevance)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Article 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 1 March 2022.
Supplementary provisions
ANNEXSupplementary provisions
ANNEX Annexes II, III and V to Regulation (EC) No 1223/2009 are amended as follows: (1) in Annex II, the following entries are added: Reference number Substance identification Chemical name/INN CAS number EC number a b c d ‘1658 Silicon carbide fibres (with diameter < 3 μm, length > 5 μm and aspect ratio ≥ 3:1) 409-21-2 308076-74-6 206-991-8 1659 Tris(2-methoxyethoxy) vinylsilane; 6-(2-methoxyethoxy)- 6-vinyl-2,5,7,10-tetraoxa-6-silaundecane 1067-53-4 213-934-0 1660 Dioctyltin dilaurate; [1] stannane, dioctyl-, bis (coco acyloxy) derivs. [2] 3648-18-8 [1] 91648- 39-4 [2] 222-883-3 [1] 293-901-5 [2] 1661 Dibenzo[def,p]chrysene; dibenzo[a,l]pyrene 191-30-0 205-886-4 1662 Ipconazole (ISO); (1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-chlorobenzyl)-5-isopropyl-1- (1H-1,2,4-triazol-1-ylmethyl)cyclopentanol 125225-28-7 115850-69-6 115937-89-8 - 1663 Bis(2-(2-methoxyethoxy)ethyl)ether; tetraglyme 143-24-8 205-594-7 1664 Paclobutrazol (ISO); (2RS,3RS)-1-(4-chlorophenyl)-4,4-dimethyl- 2-(1H-1,2,4-triazol-1- yl)pentan-3-ol 76738-62-0 - 1665 2,2-bis(bromomethyl) propane-1,3-diol 3296-90-0 221-967-7 1666 2-(4-tert-butylbenzyl) propionaldehyde 80-54-6 201-289-8 1667 Diisooctyl phthalate 27554-26-3 248-523-5 1668 2-methoxyethyl acrylate 3121-61-7 221-499-3 1669 Sodium N-(hydroxymethyl)glycinate; [formaldehyde released from sodium N-(hydroxymethyl)glycinate] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is ≥ 0,1 % w/w 70161-44-3 274-357-8 1670 Pyrithione zinc; (T-4)- bis[1-(hydroxy-.kappa.O)pyridine-2(1H)- thionato-.kappa.S]zinc 13463-41-7 236-671-3 1671 Flurochloridone (ISO); 3-chloro-4-(chloromethyl)-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one 61213-25-0 262-661-3 1672 3-(difluoromethyl)-1- methyl-N-(3',4',5'-trifluorobiphenyl-2-yl) pyrazole-4-carboxamide; fluxapyroxad 907204-31-3 - 1673 N-(hydroxymethyl)acrylamide; methylolacrylamide; [NMA] 924-42-5 213-103-2 1674 5-fluoro-1,3-dimethyl-N-[2-(4- methylpentan-2-yl) phenyl]-1H-pyrazole- 4-carboxamide; 2'- [(RS)-1,3-dimethylbutyl]-5-fluoro-1,3-dimethylpyrazole-4-carboxanilide; penflufen 494793-67-8 - 1675 Iprovalicarb (ISO); isopropyl [(2S)-3- methyl-1-{[1-(4- methylphenyl)ethyl] amino}-1-oxobutan-2- yl]carbamate 140923-17-7 - 1676 Dichlorodioctylstannane 3542-36-7 222-583-2 1677 Mesotrione (ISO); 2-[4-(methylsulfonyl)- 2-nitrobenzoyl]-1,3- cyclohexanedione 104206-82-8 - 1678 Hymexazol (ISO); 3-hydroxy-5-methylisoxazole 10004-44-1 233-000-6 1679 Imiprothrin (ISO); reaction mass of: [2,4- dioxo-(2-propyn-1-yl) imidazolidin-3-yl] methyl(1R)-cis-chrysanthemate; [2,4-dioxo-(2-propyn-1-yl) imidazolidin-3-yl] methyl(1R)-trans-chrysanthemate 72963-72-5 428-790-6 1680 Bis(α,α-dimethylbenzyl) peroxide 80-43-3; 201-279-3’ (2) in Annex III is amended as follows: (a) entry 24 is replaced by the following: Reference number Substance identification Restrictions Wording of conditions of use and warnings Chemical Name/INN Name of Common Ingredients Glossary CAS number EC number Product type, Body parts Maximum concentration in ready for use preparation Other a b c d e f g h i ‘24 Water-soluble zinc salts with the exception of zinc 4- hydroxy-benzenesulphonate (entry 25) and zinc pyrithione (Annex II, entry X) Zinc acetate, zinc chloride, zinc gluconate, zinc glutamate 1 % (as zinc)’ (b) entries 83 and 101 are deleted; (3) Annex V is amended as follows: (a) entry 8 is deleted; (b) entry 51 is replaced by the following: Reference number Substance identification Conditions Wording of conditions of use and warnings Chemical name/INN Name of Common Ingredients Glossary CAS number EC number Product type, Body parts Maximum concentration in ready for use preparation Other a b c d e f g h i ‘51 Sodium hydroxymethylamino acetate Sodium Hydroxymethylglycinate 70161-44-3 274-357-8 0,5 % Not to be used if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, if the mixture as placed on the market is ≥ 0,1 % w/w’
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.
What to look at next
Browse all EU Legal ActsEvery instrument by type and year, full text free to read section by sectionEuropean Union legislationEU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and yearEuropean Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview